Alhomoud, I. S., Talasaz, A. H., Chandrasekaran, P., Brown, R., Mehta, A., & Dixon, D. L. (2024). Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 44(9), 738–752. Portico. https://doi.org/10.1002/phar.4607

Dzierba, A. L., Stollings, J. L., & Devlin, J. W. (2023). A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(11), 1154–1165. Portico. https://doi.org/10.1002/phar.2768

Jennings, D. L., & Baker, W. L. (2023). Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(2), 115–121. Portico. https://doi.org/10.1002/phar.2757

Braghieri, L., Jennings, D. L., Bohn, B., Habal, M., Pinsino, A., Mondellini, G. M., Ladanyi, A., Latif, F., Clerkin, K., Restaino, S., Kurlansky, P., Takeda, K., Naka, Y., Demmer, R. T., Sayer, G. T., Uriel, N., Colombo, P. C., & Yuzefpolskaya, M. (2022). Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 42(9), 697–706. Portico. https://doi.org/10.1002/phar.2724